Related Experiment Video
Updated: Mar 15, 2026

06:25
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
1.7K
Cancer Seeding Risk from an Epidural Blood Patch in Patients with Leukemia or Lymphoma
Christopher J Demaree1, Jose M Soliz2, Rodolfo Gebhardt1
1Departments of Pain Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Pain Medicine (Malden, Mass.)
|August 26, 2016
Summary
Epidural blood patches (EBPs) are safe for treating postdural puncture headaches in cancer patients. This study found no instances of cancer seeding in leukemia or lymphoma patients who received EBPs.
Area of Science:
- Neurology
- Oncology
- Anesthesiology
Background:
- Lumbar punctures are common in cancer patients.
- Postdural puncture headaches are a potential complication.
- Concerns exist regarding epidural blood patches (EBPs) and neoplastic seeding in cancer patients.
Purpose of the Study:
- To evaluate the risk of central nervous system cancer seeding after epidural blood patches (EBPs) in patients with leukemia or lymphoma.
Main Methods:
- Retrospective study of institutional electronic records from 2000-2013.
- Identified patients with leukemia/lymphoma who received at least one EBP.
- Reviewed records for demographic data, cancer treatments, mortality, and evidence of new central nervous system neoplastic seeding post-EBP.
Main Results:
- Eighty patients (18 leukemia, 62 lymphoma) were included.
- None of the patients experienced new cancer or central nervous system seeding after an EBP.
- Median follow-up was 3.74 years.
Conclusions:
- Epidural blood patches (EBPs) have a low risk of causing cancer seeding in the central nervous system.
- EBPs are a viable treatment option for postdural puncture headaches in cancer patients unresponsive to conservative management.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K

